These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

446 related articles for article (PubMed ID: 36209089)

  • 1. An overview on nanoparticle-based strategies to fight viral infections with a focus on COVID-19.
    Yasamineh S; Kalajahi HG; Yasamineh P; Yazdani Y; Gholizadeh O; Tabatabaie R; Afkhami H; Davodabadi F; Farkhad AK; Pahlevan D; Firouzi-Amandi A; Nejati-Koshki K; Dadashpour M
    J Nanobiotechnology; 2022 Oct; 20(1):440. PubMed ID: 36209089
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Application of Nanotechnology in the COVID-19 Pandemic.
    Yang D
    Int J Nanomedicine; 2021; 16():623-649. PubMed ID: 33531805
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metal-based strategies for the fight against COVID-19.
    Li H; Yuan S; Wei X; Sun H
    Chem Commun (Camb); 2022 Jul; 58(54):7466-7482. PubMed ID: 35730442
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nanotechnology-based Approaches and Investigational Therapeutics against COVID-19.
    Rahman MM; Ahmed M; Islam MT; Khan MR; Sultana S; Maeesa SK; Hasan S; Hossain MA; Ferdous KS; Mathew B; Rauf A; Uddin MS
    Curr Pharm Des; 2022; 28(12):948-968. PubMed ID: 34218774
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Emerging nanotechnology role in the development of innovative solutions against COVID-19 pandemic.
    Bhutta ZA; Kanwal A; Ali M; Kulyar MF; Yao W; Shoaib M; Ashar A; Mahfooz A; Ijaz M; Ijaz N; Asif M; Nawaz S; Mahfooz MR; Kanwal T
    Nanotechnology; 2021 Sep; 32(48):. PubMed ID: 34320471
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nanomedicine to deliver biological macromolecules for treating COVID-19.
    Wilson B; Mukundan Geetha K
    Vaccine; 2022 Jun; 40(29):3931-3941. PubMed ID: 35660038
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Emergence, Transmission, and Potential Therapeutic Targets for the COVID-19 Pandemic Associated with the SARS-CoV-2.
    Patil AM; Göthert JR; Khairnar V
    Cell Physiol Biochem; 2020 Aug; 54(4):767-790. PubMed ID: 32830930
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potential Therapeutic Targets and Vaccine Development for SARS-CoV-2/COVID-19 Pandemic Management: A Review on the Recent Update.
    Anand U; Jakhmola S; Indari O; Jha HC; Chen ZS; Tripathi V; Pérez de la Lastra JM
    Front Immunol; 2021; 12():658519. PubMed ID: 34276652
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nanotechnology Responses to COVID-19.
    Ruiz-Hitzky E; Darder M; Wicklein B; Ruiz-Garcia C; Martín-Sampedro R; Del Real G; Aranda P
    Adv Healthc Mater; 2020 Oct; 9(19):e2000979. PubMed ID: 32885616
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biomedical application, drug delivery and metabolic pathway of antiviral nanotherapeutics for combating viral pandemic: A review.
    Mukherjee S; Mazumder P; Joshi M; Joshi C; Dalvi SV; Kumar M
    Environ Res; 2020 Dec; 191():110119. PubMed ID: 32846177
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Toward Nanotechnology-Enabled Approaches against the COVID-19 Pandemic.
    Weiss C; Carriere M; Fusco L; Capua I; Regla-Nava JA; Pasquali M; Scott JA; Vitale F; Unal MA; Mattevi C; Bedognetti D; Merkoçi A; Tasciotti E; Yilmazer A; Gogotsi Y; Stellacci F; Delogu LG
    ACS Nano; 2020 Jun; 14(6):6383-6406. PubMed ID: 32519842
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aptamer-Mediated Antiviral Approaches for SARS-CoV-2.
    Tan KX; Jeevanandam J; Rodrigues J; Danquah MK
    Front Biosci (Landmark Ed); 2022 Nov; 27(11):306. PubMed ID: 36472112
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Remdesivir against COVID-19 and Other Viral Diseases.
    Malin JJ; Suárez I; Priesner V; Fätkenheuer G; Rybniker J
    Clin Microbiol Rev; 2020 Dec; 34(1):. PubMed ID: 33055231
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nanotechnology against COVID-19: Immunization, diagnostic and therapeutic studies.
    Hasanzadeh A; Alamdaran M; Ahmadi S; Nourizadeh H; Bagherzadeh MA; Mofazzal Jahromi MA; Simon P; Karimi M; Hamblin MR
    J Control Release; 2021 Aug; 336():354-374. PubMed ID: 34175366
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular Insights of SARS-CoV-2 Infection and Molecular Treatments.
    Abdurrahman L; Fang X; Zhang Y
    Curr Mol Med; 2022; 22(7):621-639. PubMed ID: 34645374
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNA Mimics or Inhibitors as Antiviral Therapeutic Approaches Against COVID-19.
    Hum C; Loiselle J; Ahmed N; Shaw TA; Toudic C; Pezacki JP
    Drugs; 2021 Apr; 81(5):517-531. PubMed ID: 33638807
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Next-Generation Vaccines: Nanovaccines in the Fight against SARS-CoV-2 Virus and beyond SARS-CoV-2.
    Mufamadi MS; Ngoepe MP; Nobela O; Maluleke N; Phorah B; Methula B; Maseko T; Masebe DI; Mufhandu HT; Katata-Seru LM
    Biomed Res Int; 2023; 2023():4588659. PubMed ID: 37181817
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Emerging Advances of Nanotechnology in Drug and Vaccine Delivery against Viral Associated Respiratory Infectious Diseases (VARID).
    Seyfoori A; Shokrollahi Barough M; Mokarram P; Ahmadi M; Mehrbod P; Sheidary A; Madrakian T; Kiumarsi M; Walsh T; McAlinden KD; Ghosh CC; Sharma P; Zeki AA; Ghavami S; Akbari M
    Int J Mol Sci; 2021 Jun; 22(13):. PubMed ID: 34203268
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antiviral effects of coinage metal-based nanomaterials to combat COVID-19 and its variants.
    Mushtaq A; Iqbal MZ; Kong X
    J Mater Chem B; 2022 Jul; 10(28):5323-5343. PubMed ID: 35775993
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Animal models for studying coronavirus infections and developing antiviral agents and vaccines.
    Lin Q; Lu C; Hong Y; Li R; Chen J; Chen W; Chen J
    Antiviral Res; 2022 Jul; 203():105345. PubMed ID: 35605699
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.